Morr F
Minoxidil and finasteride oral solution for pattern hair loss. It combines a blood-flow booster with a hormone blocker.
- Category
- Hair Loss
- Active ingredients
- Minoxidil · Finasteride
- Route
- Cutaneous use
- Form
- Oral Solution
- Strengths
- 5% 60ml
Prescription and consultation requirements for Morr F vary by destination and are determined by the fulfilment partner.
Morr F details
- Condition
- Androgenetic Alopecia
- Alternative names
- minoxidil, finasteride
- Therapeutic class
- Vasodilator, 5-Alpha Reductase Inhibitor Combination
- Pharmacological class
- Topical Hair Regrowth Therapy
- Contraindications
- pregnancy; hypersensitivity to any component; broken scalp skin
- Minor side effects
- local itching; scalp dryness; mild scaling
- Moderate side effects
- erythema; burning sensation; mild hypertrichosis
- Serious side effects
- severe localised hypersensitivity, requires immediate medical attention
- Dosage forms
- Oral Solution
- Administration route
- Cutaneous use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Intas Pharmaceuticals Ltd
- Onset Time
- 2–4 months
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for adult males.
Patient summary
Minoxidil and finasteride oral solution for pattern hair loss. It combines a blood-flow booster with a hormone blocker.
Mechanism of action
Minoxidil promotes scalp blood circulation while finasteride inhibits local DHT conversion to preserve hair follicles.
Pregnancy and breastfeeding
Pregnancy: Highly contraindicated. Finasteride is teratogenic. Breastfeeding: Not applicable.